Hematology, Transfusion and Cell Therapy (Nov 2021)

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

  • Fatma YILMAZ,
  • Murat ALBAYRAK,
  • Merih REİS ARAS,
  • Senem MARAL,
  • Hacer Berna AFACAN ÖZTÜRK,
  • Pınar TIĞLIOĞLU,
  • Mesut TIĞLIOĞLU,
  • Buğra SAĞLAM

Journal volume & issue
Vol. 43
p. S50

Abstract

Read online

Case report: One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects.